Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology) (March, 10.1007/s10549-021-06417-y, 2022)-论文-万方医学网

首页> > Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology) (March, 10.1007/s10549-021-06417-y, 2022)

Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology) (March, 10.1007/s10549-021-06417-y, 2022)

导出原文传递

翻译打印收藏纠错

第一作者： Geyer, Charles E., Jr.

作者： Geyer, Charles E., Jr. ^[1] ; Bandos, Hanna ; Rastogi, Priya ; Jacobs, Samuel A. ; Robidoux, Andre ; Fehrenbacher, Louis ; Ward, Patrick J. ; Polikoff, Jonathan ; Brufsky, Adam M. ; Provencher, Louise ; Paterson, Alexander H. G. ; Hamm, John T. ; Carolla, Robert L. ; Baez-Diaz, Luis ; Julian, Thomas B. ; Swain, Sandra M. ; Mamounas, Eleftherios P. ; Wolmark, Norman

作者单位： NRG Oncol ^[1]

发布时间 2022-07-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology) (March, 10.1007/s10549-021-06417-y, 2022)

相似文献

同项目论文

相关期刊

检索历史 清除

Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology) (March, 10.1007/s10549-021-06417-y, 2022)

相似文献

同项目论文

相关期刊

检索历史清除